Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-16-010583
Filing Date
2016-02-29
Accepted
2016-02-29 16:35:17
Documents
89
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2227469z10-k.htm 10-K 1967066
2 EX-23.1 a2227469zex-23_1.htm EX-23.1 4784
3 EX-31.1 a2227469zex-31_1.htm EX-31.1 7819
4 EX-31.2 a2227469zex-31_2.htm EX-31.2 7848
5 EX-32.1 a2227469zex-32_1.htm EX-32.1 5822
12 G561719.JPG g561719.jpg GRAPHIC 38390
  Complete submission text file 0001047469-16-010583.txt   13207890

Data Files

Seq Description Document Type Size
6 EX-101.INS anac-20151231.xml EX-101.INS 3715050
7 EX-101.SCH anac-20151231.xsd EX-101.SCH 98638
8 EX-101.CAL anac-20151231_cal.xml EX-101.CAL 86014
9 EX-101.LAB anac-20151231_lab.xml EX-101.LAB 870637
10 EX-101.PRE anac-20151231_pre.xml EX-101.PRE 635583
11 EX-101.DEF anac-20151231_def.xml EX-101.DEF 399578
Mailing Address 1020 E. MEADOW CIRCLE PALO ALTO CA 94303
Business Address 1020 E. MEADOW CIRCLE PALO ALTO CA 94303 650-543-7500
Anacor Pharmaceuticals, Inc. (Filer) CIK: 0001411158 (see all company filings)

EIN.: 251854385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34973 | Film No.: 161468339
SIC: 2834 Pharmaceutical Preparations